MAP3K5 and pancreatic neoplasm: In this study, we found that treatment with an ASK1 inhibitor dramatically suppressed the proliferation of PANC1 pancreatic cancer cells, suggesting that ASK1 inhibitors may have value for the treatment of pancreatic cancer.